Navigation Links
Coulter Client Ehlers-Danlos National Foundation to Open Research Clinic in Baltimore
Date:5/14/2013

McLean, VA (PRWEB) May 14, 2013

Coulter client, Ehlers-Danlos National Foundation (EDNF) will provide funding to support a virtual center at Greater Baltimore Medical Center (GBMC) under the direction of Clair Francomano, MD, GBMC's Director of Adult Genetics. The Center will provide comprehensive clinical care for patients, professional education for physicians and a research component. Elliot Clark, EDNF board chairman, and Shane Robinson, EDNF executive director, were on hand at GBMC on Wednesday, May 8 to formally sign an agreement officially announcing the partnership between EDNF and GBMC.

"Partnering with the Greater Baltimore Medical Center to open the first ever EDNF Center for Clinical Care and Research is an exciting new initiative for the foundation," said Shane Robinson, EDNF executive director. "EDS often goes undiagnosed because physicians are not aware of the disease. The funding EDNF is providing to establish this clinic is a major step forward in advancing our mission to educate healthcare practitioners and patients and provide treatment to help people living with EDS."

Clinical research, education, and treatment for Ehlers–Danlos syndrome (EDS), a group of inherited connective tissue disorders for which there is no cure, took a significant step forward on May 8 with the establishment of the first ever Ehlers-Danlos National Foundation Center for Clinical Care and Research at GBMC's Harvey Institute for Human Genetics. May is Ehlers-Danlos Syndrome Awareness Month, and the disease is believed to affect about one in 2,500 to one in 5,000 individuals worldwide.

"We are extremely grateful to EDNF for their support which will allow us to explore new treatment options for patients and raise awareness among physicians. It is our hope that these efforts will lead to earlier diagnosis and better treatment options for patients with EDS, and provide the opportunity for continued research into the causes of EDS," said Dr. Francomano. "Knowledge concerning the underlying causes of the disease will enable us to seek rationale therapies for this complex and disabling condition."

About Ehlers-Danlos National Foundation (EDNF): EDNF is the leading authority for Ehlers-Danlos Syndrome (EDS), a group of genetic connective tissue disorders. To support research and education about EDS to prevent disfigurement, crippling, and premature death through early and accurate diagnosis, EDNF increases awareness about EDS by fostering and funding research, generating and distributing accurate and responsible information, and delivering recommendations for those seeking diagnosis of problems that have been a life-long mystery. EDNF also provides support to those who have been diagnosed with EDS by offering information and emotional validation for the newly diagnosed wrestling with what a genetic disorder means for them and their families, and provides tips for those who have lived with EDS for years, including day-to-day inspiration and news. EDNF’s members are physicians and other medical practitioners, researchers, people with EDS, and friends. For more information, visit http://www.ednf.org.

About Dr. Francomano: Dr. Francomano received her undergraduate degree at Yale University and her medical degree from The Johns Hopkins University School of Medicine. She trained in internal medicine and medical genetics at Johns Hopkins and joined the full-time Hopkins faculty in 1984. She joined GBMC's Harvey Institute of Human Genetics in 2005. Dr. Francomano is an Associate Professor of Medicine at Johns Hopkins University School of Medicine. She has held positions as Clinical Director and Chief of the Medical Genetics Branch at the National Human Genome Research Institute, National Institutes of Health and Chief of the Human Genetics and Integrative Medicine Section in the Laboratory of Genetics, National Institute on Aging.

Dr. Francomano is board-certified in internal medicine, clinical genetics and clinical molecular genetics. She is a member of the American College of Physicians, the American Society of Human Genetics and the American Society for Clinical Investigation, and is a founding fellow of the American College of Medical Genetics.

In 2008, and every year since, Dr. Francomano has been named among "Baltimore's Best Medical Geneticists" by Baltimore Magazine. Her clinical and research interests include the hereditary disorders of connective tissue and skeletal dysplasias. She received EDNF's Shining Star award in 2012 for her dedication to people with EDS.

About GBMC: GBMC HealthCare system includes Greater Baltimore Medical Center, a 270-bed acute care not-for-profit hospital which opened in 1965 and provides "Health, Healing and Hope"; Greater Baltimore Medical Associates, a group of more than 40 multi-specialty physician practices on the hospital's Towson campus and locations across the region; Greater Baltimore Health Alliance, an alliance of GBMC-employed and private practicing physician partners; Gilchrist Hospice Care, Maryland's largest hospice organization offering care in-home as well as in a 34-bed inpatient center on the GBMC Towson campus and at a 10-bed inpatient center in Howard County; and the GBMC Foundation, which raises funds to support the organization's mission. For more information, visit http://www.gbmc.org.

Read the full story at http://www.prweb.com/releases/Coulter/EDNF/prweb10728485.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. James George, MD: 2012 ASH Wallace H. Coulter Award for Lifetime Achievement in Hematology
2. Maui'd Forever Clients Get To Preview Latest Activity Video For The Inaccessible Napali Coastline
3. SmartSearch Marketing, a B2B Search Marketing Agency, Adds Content Strategy Manager to Serve Rapid Client Growth
4. Public Relations Firm Now Offering SEO Services for Clients in Los Angeles
5. Power Up For Profits! Client Releases First Book at the Age of 71
6. MyNetDiary Offers New Way to Connect Clients to their Dietitian, Nutritionist, or Trainer
7. Studio Pulse Announces New Website Making It Easier for Clients to Learn About Their Program and Sign Up for Classes Online
8. Passages Malibu Reaffirms Its Unshakable Commitment to Total Client Privacy
9. One Third of Truven Health’s 15 Top Health Systems Are HealthLine Systems’ Clients
10. Acclaim Health Implements CellTrak CareManager™ to Enhance Client Care
11. QCI Mold and Water Damage Now Recommends All New Fiberlock HydroBoost Product to Commercial and Residential Clients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: